X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA UNICHEM LAB NATCO PHARMA/
UNICHEM LAB
 
P/E (TTM) x 34.7 22.6 154.0% View Chart
P/BV x 17.7 2.4 744.5% View Chart
Dividend Yield % 0.6 0.8 80.9%  

Financials

 NATCO PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
UNICHEM LAB
Mar-16
NATCO PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs877334 262.6%   
Low Rs424174 243.4%   
Sales per share (Unadj.) Rs223.4146.9 152.1%  
Earnings per share (Unadj.) Rs31.111.9 261.2%  
Cash flow per share (Unadj.) Rs40.316.2 248.8%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.80.8 97.7%  
Book value per share (Unadj.) Rs219.5105.1 208.8%  
Shares outstanding (eoy) m33.0790.84 36.4%   
Bonus/Rights/Conversions PAESOP-  
Price / Sales ratio x2.91.7 168.3%   
Avg P/E ratio x20.921.4 98.0%  
P/CF ratio (eoy) x16.115.7 102.9%  
Price / Book Value ratio x3.02.4 122.6%  
Dividend payout %16.116.8 95.7%   
Avg Mkt Cap Rs m21,50423,073 93.2%   
No. of employees `000NA5.7 0.0%   
Total wages/salary Rs m1,1282,558 44.1%   
Avg. sales/employee Rs ThNM2,352.5-  
Avg. wages/employee Rs ThNM450.9-  
Avg. net profit/employee Rs ThNM190.4-  
INCOME DATA
Net Sales Rs m7,38913,346 55.4%  
Other income Rs m167192 87.1%   
Total revenues Rs m7,55613,538 55.8%   
Gross profit Rs m1,7931,639 109.4%  
Depreciation Rs m304390 78.1%   
Interest Rs m36629 1,271.5%   
Profit before tax Rs m1,2901,412 91.3%   
Minority Interest Rs m460-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m309293 105.5%   
Profit after tax Rs m1,0271,080 95.1%  
Gross profit margin %24.312.3 197.6%  
Effective tax rate %23.920.7 115.5%   
Net profit margin %13.98.1 171.8%  
BALANCE SHEET DATA
Current assets Rs m3,6815,979 61.6%   
Current liabilities Rs m3,1232,432 128.4%   
Net working cap to sales %7.626.6 28.4%  
Current ratio x1.22.5 47.9%  
Inventory Days Days8963 141.9%  
Debtors Days Days5960 97.2%  
Net fixed assets Rs m7,6856,403 120.0%   
Share capital Rs m331182 182.0%   
"Free" reserves Rs m6,6709,293 71.8%   
Net worth Rs m7,2599,548 76.0%   
Long term debt Rs m955230 414.5%   
Total assets Rs m11,95712,843 93.1%  
Interest coverage x4.550.0 9.0%   
Debt to equity ratio x0.10 545.2%  
Sales to assets ratio x0.61.0 59.5%   
Return on assets %11.78.6 134.9%  
Return on equity %14.211.3 125.1%  
Return on capital %20.714.3 144.6%  
Exports to sales %39.429.2 134.7%   
Imports to sales %5.76.3 89.8%   
Exports (fob) Rs m2,9083,900 74.6%   
Imports (cif) Rs m421847 49.7%   
Fx inflow Rs m3,4454,356 79.1%   
Fx outflow Rs m7031,162 60.5%   
Net fx Rs m2,7433,194 85.9%   
CASH FLOW
From Operations Rs m1,4401,119 128.7%  
From Investments Rs m-1,089-853 127.6%  
From Financial Activity Rs m-353-334 105.5%  
Net Cashflow Rs m-1-68 2.2%  

Share Holding

Indian Promoters % 52.0 50.1 103.9%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 15.1 51.9%  
FIIs % 16.6 3.0 554.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 31.7 82.0%  
Shareholders   25,395 20,176 125.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   WYETH LTD  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare NATCO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 8-QTR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS